Brief: Access Bio to set up new wholly owned subsidiary for 15 bln won
14/11/2016 06:49
Nov 14 (Reuters) - Access Bio Inc 950130.KQ :
* Says it will invest 15 billion won to set up a new wholly
owned subsidiary, which will be engaged in manufacturing
pharmaceutical preparations for in vitro diagnosis and medical
device business
* Says the new subsidiary will be capitalized at 15 billion
won and the company will hold entire 3 million shares of the
subsidiary
* Expected transaction settlement date is Jan. 10, 2017
Source text in Korean: https://goo.gl/24F2GE
Further company coverage: 950130.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))